(Q40095585)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

17 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Targeting EGFR in bladder cancer (English)

1 reference

17 September 2017

G J Villares

1

1 reference

17 September 2017

M Zigler

2

1 reference

17 September 2017

K Blehm

3

1 reference

17 September 2017

C Bogdan

4

1 reference

17 September 2017

D McConkey

5

1 reference

17 September 2017

D Colin

6

1 reference

17 September 2017

Menashe Bar-Eli

7

1 reference

17 September 2017

publication date

10 August 2007

1 reference

17 September 2017

published in

World Journal of Urology

1 reference

17 September 2017

volume

25

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

573-579

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-007-0202-7

17 September 2017

exact match

0 references

cites work

Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00345-007-0202-7

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00345-007-0202-7

Long-term outcome related to epidermal growth factor receptor status in bladder cancer

21 January 2018

1 reference

12 December 2020

Epidermal growth factor

1 reference

12 December 2020

Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.

1 reference

12 December 2020

Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice

1 reference

12 December 2020

Antagonistic and agonistic effects of quinazoline tyrosine kinase inhibitors on mutant EGF receptor function

1 reference

12 December 2020

EGFR and EGFRvIII expression in primary breast cancer and cell lines.

1 reference

12 December 2020

Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.

1 reference

12 December 2020

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice

1 reference

12 December 2020

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas

1 reference

12 December 2020

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

1 reference

12 December 2020

Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme

1 reference

12 December 2020

Transformational and altered signal transduction by a naturally occurring mutant EGF receptor

1 reference

12 December 2020

Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family

1 reference

12 December 2020

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

1 reference

12 December 2020

Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors

1 reference

12 December 2020

Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.

1 reference

12 December 2020

Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor

1 reference

12 December 2020

Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways.

1 reference

12 December 2020

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

1 reference

12 December 2020

Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Integrating basic science and clinical research in bladder cancer: update from the first bladder Specialized Program of Research Excellence (SPORE).

1 reference

12 December 2020

Epidermal growth factor receptor expression: predictive value for the outcome after cystectomy for bladder cancer?

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

1 reference

12 December 2020

Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas

1 reference

12 December 2020

Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression

1 reference

12 December 2020

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas

1 reference

12 December 2020

Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells

1 reference

12 December 2020

Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII.

1 reference

12 December 2020

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

1 reference

12 December 2020

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.

1 reference

12 December 2020

The voiding pattern in infants with dilating reflux

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1007/S00345-007-0202-7

Identifiers

DOI

10.1007/S00345-007-0202-7

1 reference

Dimensions Publication ID

17 September 2017

1019389580

0 references

1 reference